Eric Sheldon

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials

Eric Plennevaux, Eric Sheldon, Mark M. Blatter et al. · The Lancet · 2009 · 246 citations

Vaccination, Immunology, Single Vaccination +8

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

David N. Taylor, John J. Treanor, Eric Sheldon et al. · Vaccine · 2012 · 130 citations

Vaccination, Cross-protection, Vaccine Development +10

Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial

C. Birbara, Anthony D Puopolo, David Muñoz et al. · Journal of Pain · 2003 · 119 citations

Pain Therapy, Pain Disorders, Health Sciences +10

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin et al. · The Lancet Infectious Diseases · 2017 · 118 citations · Full text

Vaccinology, Vaccination, Vaccine Safety +9

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell et al. · Annals of Oncology · 2015 · 106 citations · Full text

Oncology, Heat Shock, Medicine +7